Dear all
A further update on my situation over here in cold and wet Europe. Since I last wrote I have been working my way through the UK health system to get an appoinment with an oncologist. This is now scheduled for Friday, and in the meantime I have been busy. I just received blood test results which show my AFP to have stablised within normal levels, meaning that for now I am a 'true' stage 1b and not a 1c. For this I am happy. I have also been in contact with my both the US doctor who saw me in DC and, just moments ago, Dr Joel Sheinfeld at Sloan Kettering who was kind enough to take five minutes to chat.
Basically, because of a degree of angiolymphatic invasion, if I was in the US I would be referred for an RPLND quicksharp. However, as I indicated previously, as I am in the UK this is not likely to be offered as as a first option for a stage 1b patient. Instead, it looks like I will be offered the chance of surveillance or two courses of chemotherapy. I am writing to gauge opinion - following discussion with the US doctors (and also through the very helpful people on this list) I am inclined to believe that chemotherapy might be (almost) ineffective at this point (because of the high amount of immature teratoma in my removed tumour (95%) anything left at this point is likely to include a high teratoma component - I hope I'm putting this right). If there is recurrence it seems that chemotherapy would rear its ugly head further down the line anyway, so is there any point in exposing myself to it before I know it is really necessary? What about going with surveillance and then going with the needed treatment if and when something recurrs? (Incidentally I am under no illusions about the possibility of this due to the angiolymphatic invasion. anyone have any stats on recurrence by the way?)
I guess the next step, however, is to speak with the English oncologist and then get another CT scan to double check the nodes. Any advice is appreciated on how I might proceed, and I'll keep you posted on how things pan out. Happy Christmas from Copenhagen where I'm currently working, and good luck to you all!
Stuart
S/P: Right Radical Orchiectomy Nov 22, 2006
Assessment: Non-Seminoma germ cell tumour Clinical stage 1b
Histologic Type: Mixed germ cell tumour - Immature teratoma 95%/Yolk sac
tumour 5%
Primary tumour pT2, tumour limited to the testis and epididymis with
vascular/lymphatic invasion
Tumour size: 6cm in greatest dimension, Additional dimensions 4.5X4.0
A further update on my situation over here in cold and wet Europe. Since I last wrote I have been working my way through the UK health system to get an appoinment with an oncologist. This is now scheduled for Friday, and in the meantime I have been busy. I just received blood test results which show my AFP to have stablised within normal levels, meaning that for now I am a 'true' stage 1b and not a 1c. For this I am happy. I have also been in contact with my both the US doctor who saw me in DC and, just moments ago, Dr Joel Sheinfeld at Sloan Kettering who was kind enough to take five minutes to chat.
Basically, because of a degree of angiolymphatic invasion, if I was in the US I would be referred for an RPLND quicksharp. However, as I indicated previously, as I am in the UK this is not likely to be offered as as a first option for a stage 1b patient. Instead, it looks like I will be offered the chance of surveillance or two courses of chemotherapy. I am writing to gauge opinion - following discussion with the US doctors (and also through the very helpful people on this list) I am inclined to believe that chemotherapy might be (almost) ineffective at this point (because of the high amount of immature teratoma in my removed tumour (95%) anything left at this point is likely to include a high teratoma component - I hope I'm putting this right). If there is recurrence it seems that chemotherapy would rear its ugly head further down the line anyway, so is there any point in exposing myself to it before I know it is really necessary? What about going with surveillance and then going with the needed treatment if and when something recurrs? (Incidentally I am under no illusions about the possibility of this due to the angiolymphatic invasion. anyone have any stats on recurrence by the way?)
I guess the next step, however, is to speak with the English oncologist and then get another CT scan to double check the nodes. Any advice is appreciated on how I might proceed, and I'll keep you posted on how things pan out. Happy Christmas from Copenhagen where I'm currently working, and good luck to you all!
Stuart
S/P: Right Radical Orchiectomy Nov 22, 2006
Assessment: Non-Seminoma germ cell tumour Clinical stage 1b
Histologic Type: Mixed germ cell tumour - Immature teratoma 95%/Yolk sac
tumour 5%
Primary tumour pT2, tumour limited to the testis and epididymis with
vascular/lymphatic invasion
Tumour size: 6cm in greatest dimension, Additional dimensions 4.5X4.0
Comment